Pfizer
PFE
2,231 hedge funds and large institutions have $150B invested in Pfizer in 2018 Q1 according to their latest regulatory filings, with 110 funds opening new positions, 931 increasing their positions, 971 reducing their positions, and 93 closing their positions.
18% more first-time investments, than exits
New positions opened: 110 | Existing positions closed: 93
10% more funds holding in top 10
Funds holding in top 10: 163 → 180 (+17)
0% more call options, than puts
Call options by funds: $881M | Put options by funds: $881M
1% less funds holding
Funds holding: 2,244 → 2,231 (-13)
0.72% less ownership
Funds ownership: 71.61% → 70.89% (-0.72%)
3% less capital invested
Capital invested by funds: $154B → $150B (-$4.89B)
4% less repeat investments, than reductions
Existing positions increased: 931 | Existing positions reduced: 971
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$281M |
| 2 |
BlackRock
New York
|
+$246M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$229M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$181M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$168M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$592M |
| 2 |
JP Morgan Chase
New York
|
-$492M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$399M |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$231M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$198M |
PFE Hedge Fund Activity: Q1 2018 in Review
2,231 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q1 2018, worth a combined $150B — down 3.2% from $154B a quarter earlier.
Buyers outnumbered sellers: 110 funds opened new PFE positions and 93 closed out — a net gain of 17 holders — while 931 added to existing stakes and 971 trimmed.
The largest buyer was Deutsche Bank, adding an estimated $281M. The largest seller was State Street, cutting an estimated $592M.
- 2,231 institutional investors held Pfizer (PFE) as of Q1 2018, down from 2,244 in Q4 2017.
- Funds reported $150B of Pfizer stock for Q1 2018, down 3.2% quarter-over-quarter.
- 110 funds opened new Pfizer positions in Q1 2018 and 93 closed out, a net change of +17 holders.
- The largest Pfizer buyer in Q1 2018 was Deutsche Bank, an estimated $281M added.
- The largest Pfizer seller in Q1 2018 was State Street, an estimated $592M sold.
Based on aggregated 13F filings for Q1 2018.